Brust-Zentrum Zurich enters into a strategic partnership with Affidea

Bär & Karrer advised on the sale of Brust-Zentrum Zurich, a Swiss medical center specialised in the diagnosis and professional treatment of the breast. The owners of Brust-Zentrum Zurich have entered a strategic alliance with Affidea, a european provider of advanced diagnostic imaging, cancer therapies and outpatient services.

With this partnership, Affidea Switzerland expands in the breast care market, offering integrated care services for women’s health, while at the same time enlarging its geographic footprint in the canton of Zurich. In Switzerland, the combined business of Affidea and Brust-Zentrum Zürich brings together more than 280 professionals in 11 centers, seeing more than 145.000 patients every year.

The advisors

Brust Zentrum Zurich has been advised throughout the transaction process by Capitalmind on the financial side and Bär & Karrer on the legal side. Affidea was advised by Niederer Kraft Frey on the legal side and by KPMG on the financial side.

Bär & Karrer team advising Brust-Zentrum Zurich was co-led by partners Christoph Neeracher (pictured right) and Philippe Seiler (pictured left) and included associates Elisabeth Rinderknecht, Luca Tarzia and junior associate Dominique Nguyen (all m&a), partner Susanne Schreiber, associates Elena Kumashova and Alessia Suter (all tax) as well as counsel Micha Schilling (financing).